Viewing Study NCT01863550


Ignite Creation Date: 2025-12-24 @ 5:16 PM
Ignite Modification Date: 2026-04-06 @ 12:51 AM
Study NCT ID: NCT01863550
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-08
First Post: 2013-05-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module